Want to join the conversation?
$GRPN 2Q15 Call: Gross profit was $337MM or about flat to 2Q14, had it not been for a $28MM FX headwind. Gross profit was negatively impacted by a significant increase in order discounts, as order discounts are reported as a reduction to billings rather than as a marketing expense. Adjusted EBITDA was $61MM compared to $60MM in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?